167 related articles for article (PubMed ID: 35338990)
1. Treat more than heat-New therapeutic implications of Cimicifuga racemosa through AMPK-dependent metabolic effects.
Drewe J; Boonen G; Culmsee C
Phytomedicine; 2022 Jun; 100():154060. PubMed ID: 35338990
[TBL] [Abstract][Full Text] [Related]
2. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.
Winterhoff H; Spengler B; Christoffel V; Butterweck V; Löhning A
Maturitas; 2003 Mar; 44 Suppl 1():S51-8. PubMed ID: 12609559
[TBL] [Abstract][Full Text] [Related]
3. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
Wuttke W; Seidlová-Wuttke D; Gorkow C
Maturitas; 2003 Mar; 44 Suppl 1():S67-77. PubMed ID: 12609561
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review.
Laakmann E; Grajecki D; Doege K; zu Eulenburg C; Buhling KJ
Gynecol Endocrinol; 2012 Sep; 28(9):703-9. PubMed ID: 22385322
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.
Nappi RE; Malavasi B; Brundu B; Facchinetti F
Gynecol Endocrinol; 2005 Jan; 20(1):30-5. PubMed ID: 15969244
[TBL] [Abstract][Full Text] [Related]
6. Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.
Castelo-Branco C; Navarro C; Beltrán E; Losa F; Camacho M;
Gynecol Endocrinol; 2022 May; 38(5):379-384. PubMed ID: 35403534
[TBL] [Abstract][Full Text] [Related]
7. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).
Huntley A
Expert Opin Drug Saf; 2004 Nov; 3(6):615-23. PubMed ID: 15500420
[TBL] [Abstract][Full Text] [Related]
8. The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints--an observational study.
Drewe J; Zimmermann C; Zahner C
Phytomedicine; 2013 Jun; 20(8-9):659-66. PubMed ID: 23537746
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacologic and clinical studies using Cimicifuga racemosa in climacteric complaints].
Winterhoff H; Butterweck V; Jarry H; Wuttke W
Wien Med Wochenschr; 2002; 152(15-16):360-3. PubMed ID: 12244879
[TBL] [Abstract][Full Text] [Related]
10. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.
Villaseca P
Climacteric; 2012 Apr; 15(2):115-24. PubMed ID: 22148909
[TBL] [Abstract][Full Text] [Related]
11. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa).
Wuttke W; Jarry H; Haunschild J; Stecher G; Schuh M; Seidlova-Wuttke D
J Steroid Biochem Mol Biol; 2014 Jan; 139():302-10. PubMed ID: 23459142
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
[TBL] [Abstract][Full Text] [Related]
13. A review of non-hormonal options for the relief of menopausal symptoms.
Albertazzi P
Treat Endocrinol; 2006; 5(2):101-13. PubMed ID: 16542050
[TBL] [Abstract][Full Text] [Related]
14. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
[TBL] [Abstract][Full Text] [Related]
15. The Cimicifuga racemosa special extract BNO 1055 prevents hot flashes in ovariectomized rats.
Kapur P; Wuttke W; Seidlova-Wuttke D
Phytomedicine; 2010 Sep; 17(11):890-4. PubMed ID: 20696560
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".
Beer AM; Osmers R; Schnitker J; Bai W; Mueck AO; Meden H
Gynecol Endocrinol; 2013 Dec; 29(12):1022-5. PubMed ID: 23992293
[TBL] [Abstract][Full Text] [Related]
17. Cimicifuga racemosa: a systematic review of its clinical efficacy.
Borrelli F; Ernst E
Eur J Clin Pharmacol; 2002 Jul; 58(4):235-41. PubMed ID: 12136368
[TBL] [Abstract][Full Text] [Related]
18. Effects of
Furtado Macruz C; Lima SMRR
J Obstet Gynaecol; 2022 Oct; 42(7):3236-3240. PubMed ID: 35993523
[TBL] [Abstract][Full Text] [Related]
19. The growth inhibitory activity of the Cimicifuga racemosa extract Ze 450 is mediated through estrogen and progesterone receptors-independent pathways.
Garita-Hernandez M; Calzado MA; Caballero FJ; Macho A; Muñoz E; Meier B; Brattström A; Fiebich BL; Appel K
Planta Med; 2006 Mar; 72(4):317-23. PubMed ID: 16557472
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness and safety of the treatment of menopausal syndrome with Cimicifuga racemosa dry extract].
Radowicki S; Skórzewska K; Rudnicka E; Szlendak-Sauer K; Wierzba W
Ginekol Pol; 2006 Sep; 77(9):678-83. PubMed ID: 17219796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
